ESC Professional Premium Access

Pulmonary hypertension in patients with heart failure with reduced ejection fraction: impact of the new definition of pulmonary hypertension

Congress Presentation

About the speaker

Doctor Samuel Vysocansky

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)
1 presentation
0 follower

4 more presentations in this session

Validation of the OPTICS and H2FPEF risk scores for post-capillary pulmonary hypertension in an asian cohort

Speaker: Mr H. Jiang (Singapore, SG)


PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension

Speaker: Doctor T. Hofbauer (Vienna, AT)


Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study.

Speaker: Doctor M. Toma (Genoa, IT)


Pulmonary hypertension associated with left heart disease among hospitalized patients: analysis of the Nationwide Inpatient Sample

Speaker: Mr I. Farmakis (Mainz, DE)


Access the full session

Right and left heart disease: which comes first?

Speakers: Doctor S. Vysocansky, Mr H. Jiang, Doctor T. Hofbauer, Doctor M. Toma, Mr I. Farmakis

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb